Heparin-induced thrombocytopenia in the presence of a heparin-bonded bypass graft

Vascular

Volumn 19, Issue 6, 2011, Pages 338-341

  Wheatcroft, M D ^a   Greco, E ^a   Tse, L ^a   Roche Nagle, Graham ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Heparin bonded graft; Heparin induced thrombocytopenia; Peripheral arterial disease

Indexed keywords

ARGATROBAN; ENOXAPARIN; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; LEPIRUDIN; SEROTONIN; WARFARIN;

ABOVE KNEE AMPUTATION; AGED; ARTICLE; AXILLOFEMORAL ARTERY ANASTOMOSIS; BLOOD ANALYSIS; BLOOD VESSEL GRAFT; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DACRON VASCULAR PROSTHESIS; DEVICE REMOVAL; DRUG WITHDRAWAL; FEMALE; GRAFT PATENCY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; LEG THROMBOSIS; LIMB ISCHEMIA; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROFUNDAPLASTY; SEROTONIN RELEASE; THROMBOCYTE COUNT; VASCULAR SURGERY;

AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS; FEMALE; GRAFT OCCLUSION, VASCULAR; HEPARIN; HUMANS; PERIPHERAL ARTERIAL DISEASE; POLYTETRAFLUOROETHYLENE; THROMBOCYTOPENIA;

EID: 84858990152     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1258/vasc.2011.cr0280     Document Type: Article

References (17)

1. Bandyk DF, Bergamini TM, Towne JT, Schmitt DD, Seabrook GR. Durability of vein graft revision: the outcome of secondary procedures. J Vasc Surg 1991;13:200-9
2. Lilly MP, Flinn WR, McCarthy WJ III, Courtney DF, Yao JS, Bergan JJ. The effect of distal arterial anatomy on the success of popliteal aneurysm repair. J Vasc Surg 1988;7:653-60
3. Pulli R, Dorigo W, Castelli P, et al. Propaten Italian Registry Group. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. J Vasc Surg 2010;51:1167-77
4. Hugl B, Nevelsteen A, Daenens K, et al. PEPE II Study Group. PEPE II - a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: determinants of patency. J Cardiovasc Surg (Torino) 2009;50:195-203
5. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Vasc Surg 2007;45 (Suppl. S):S5-67
6. Begovac PC, Thomson RC, Fisher JL, Hughson A, Gällhagen A. Improvements in GORE-TEX® Vascular Graft performance by Carmeda® bioactive surface heparin immobilization. Eur J Vasc Endovasc Surg 2003;25:432-7 (Pubitemid 36603293)
7. Warkentin TE. Heparin-induced thrombocytopenia. Circulation 2004;110:e454-8
8. Cuker A. Heparin-induced thrombocytopenia: present and future. J Thromb Thrombolysis 2011;31:353-66
9. Arepally GM, Ortel TL. Clinical practice. Heparin induced thrombocytopenia. N Engl J Med 2006;355:809-17
10. Warkentin TE, Eikelboom JW. Who is (still) getting HIT? Chest 2007;131:1620-2 (Pubitemid 46981609)
11. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332: 1330-5
12. Heyligers JM, Lisman T, Verhagen HJ, Weeterings C, de Groot PG, Moll FL. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans. J Vasc Surg 2008;47:324-9 (Pubitemid 351172659)
13. Almeida JI, Liem TK, Silver D. Heparin-bonded grafts induce platelet aggregation in the presence of heparin-associated antiplatelet antibodies. J Vasc Surg 1998;27:896-900; discussion 900-1
14. Mureebe L, Graham JA, Bush RL, Silver D. Risk of heparin-induced thrombocytopenia from heparin-bonded vascular prostheses. Ann Vasc Surg 2007;21:719-22 (Pubitemid 350016746)
15. Laster J, Silver D. Heparin-coated catheters and heparin-induced thrombocytopenia. J Vasc Surg 1988;7:667-72
16. Thakur S, Pigott JP, Comerota AJ. Heparin-induced thrombocytopenia after implantation of a heparin-bonded polytetrafluoroethylene lower extremity bypass graft: a case report and plan for management. J Vasc Surg 2009;49:1037-40
17. Lincoff AM, Bittl JA, Harrington RA, et al. REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/ IIIa blockade during percutaneous coronary intervention. REPLACE - 2 randomized trial. JAMA 2003;289:853-63 (Pubitemid 37430344)